Showing results (1931-1940 of 31,409) with videos related to
Sort By:
Pageof 3,141
Journal of Medicinal Chemistry|October 28, 1994
Inhibition of topoisomerase II catalytic activity by pyridoacridine alkaloids from a Cystodytes sp. ascidian: a mechanism for the apparent intercalator-induced inhibition of topoisomerase IIL A McDonald, G S Eldredge, L R Barrows, et al.Journal of Medicinal Chemistry|November 11, 1994
L-N6-(1-iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthaseW M Moore, R K Webber, G M Jerome, et al.Journal of Medicinal Chemistry|June 24, 1994
Studies on neurokinin antagonists. 4. Synthesis and structure-activity relationships of novel dipeptide substance P antagonists: N2-[(4R)-4-hydroxy-1-[(1-methyl-1H-indol-3-yl)carbonyl]-L-prolyl]-N- methyl-N-(phenylmethyl)-3-(2-naphthyl)-L-alaninamide and its related compoundsD Hagiwara, H Miyake, N Igari, et al.Journal of Medicinal Chemistry|July 8, 1994
Comparison of the conformation of active and nonactive backbone cyclic analogs of substance P as a tool to elucidate features of the bioactive conformation: NMR and molecular dynamics in DMSO and waterS G Grdadolnik, D F Mierke, G Byk, et al.Journal of Medicinal Chemistry|November 24, 1995
(E)-8-benzylidene derivatives of 2-methyl-5-(3-hydroxyphenyl)morphans: highly selective ligands for the sigma 2 receptor subtypeC M Bertha, B J Vilner, M V Mattson, et al.Journal of Medicinal Chemistry|November 24, 1995
N-3-substituted pyrimidinones as potent, orally active, AT1 selective angiotensin II receptor antagonistsA Salimbeni, R Canevotti, F Paleari, et al.Journal of Medicinal Chemistry|July 21, 1995
Structure-activity relationships of the potent combined endothelin-A/endothelin-B receptor antagonist Ac-DDip16-Leu-Asp-Ile-Ile-Trp21: development of endothelin-B receptor selective antagonistsW L Cody, J X He, P L DePue, et al.Journal of Medicinal Chemistry|July 21, 1995
(E)-4-(2-[[3-(indol-5-yl)-1-oxo-2-butenyl]amino]phenoxy)butyric acid derivatives: a new class of steroid 5 alpha-reductase inhibitors in the rat prostate. 1T Kumazawa, H Takami, N Kishibayashi, et al.Journal of Medicinal Chemistry|July 21, 1995
(+/-)-(Z)-2-(aminomethyl)-1-phenylcyclopropanecarboxamide derivatives as a new prototype of NMDA receptor antagonistsS Shuto, H Takada, D Mochizuki, et al.Journal of Medicinal Chemistry|July 21, 1995
Flexible 1-[(2-aminoethoxy)alkyl]-3-ar(o)yl(thio)ureas as novel acetylcholinesterase inhibitors. Synthesis and biochemical evaluationJ L Vidaluc, F Calmel, D C Bigg, et al.Pageof 3,141